The AI in bioinformatics market is projected to reach $37.63 billion by 2030 at a 43.7% CAGR, driven by precision medicine, AI-driven drug discovery, and genomic data analysis.
Read More
The aesthetic medicine market is projected to reach $110.76 billion by 2030 at an 8.4% CAGR, driven by non-invasive treatments, AI-driven planning, and personalized cosmetic solutions.
Read More
Advanced therapy medicinal products market to reach $124.43 by 2030 at 19.3% CAGR, driven by precision medicine, gene therapies, and biotech innovation.
Read More
The advanced therapeutics pharmaceutical outsourcing market is projected to reach $10.73 billion by 2030 at a 5.0% CAGR, driven by cell & gene therapy outsourcing and CDMO expansion.
Read More
The adult vaccines market is projected to reach $37.51 billion by 2030 at a 9.2% CAGR, driven by mRNA advancements, immunization programs, and growing vaccine awareness.
Read More
The adrenoleukodystrophy drugs market is set to reach $1.13 billion by 2030 at a 10.3% CAGR, driven by gene therapy, orphan drug incentives, and early diagnosis programs.
Read More
The Adhatoda Vasica extract market is projected to reach $1.98 billion by 2030 at an 8.9% CAGR, driven by herbal respiratory remedies, ayurvedic products, and phytochemical research.
Read More
The adenosine market is set for rapid growth, reaching $1.83 billion by 2030 at a 10.9% CAGR, driven by cardiovascular use, oncology research, and biotech advances.
Read More
The AAV vectors in gene therapy market is poised for rapid growth, reaching $6.99 billion by 2030 at a 17.2% CAGR, driven by gene therapy launches and scalable vector manufacturing.
Read More
The adalimumab, infliximab, and etanercept biosimilars market is set for rapid growth, reaching $8.05 billion by 2030 at a 10.1% CAGR, driven by cost-effective TNF-alpha therapies.
Read More